Mast-R-Prep™ is ART’s proprietary, chlorhexidine-based, one-step surgical skin prep product. It has the antimicrobial profile and several other characteristics (eg detectable and tackiness) most desirable to surgeons.
Market Size – US: $1 Billion, Worldwide: $2 Billion
We have completed phase 1 and 2 clinical trials for Mast-R-Prep™. Our independent lab compared our product, Mast-R-Prep™, to the market leader Chloraprep (Chloraprep was originally acquired by Cardinal Health for $490 million in 2008). Our in vitro results showed superior delivery of Chlorhexidine Gluconate (CHG) over time compared to Chloraprep.
Ultrafiltration Membrane 41708
Our independent lab compared our product, Mast-R-Prep™, to the market leader Chloraprep in vivo. Our in vivo results showed Mast-R-Prep™’s superior bacterial kill rate over time compared to Chloraprep.
Mast-R-Prep In Vivo
Please note the important FDA timepoints at twenty four and forty eight hours.”
Please see more information and a brief video on our Target Market opportunities page.
